Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Human Continuum is a longevity-focused investment and operations company co-founded by Dr. David Sinclair and Tristan Edwards. It serves as the foundational entity and holding company for Life Biosciences, a biotechnology firm dedicated to developing therapeutics that target the biology of aging. The company's mission is to extend healthy human lifespan by addressing the underlying causes of age-related decline through a diverse portfolio of daughter companies. Human Continuum integrates scientific research with strategic investment to advance breakthroughs in epigenetic reprogramming, autophagy, and mitochondrial health. The company's approach is centered on the 'Information Theory of Aging,' which posits that aging is a result of the loss of epigenetic information.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Human Continuum.